Search
Descriptor English: Cabergoline
Descriptor Spanish: Cabergolina
Descriptor cabergolina
Entry term(s) 1-((6-alilergolin-8beta-il)carbonil)-1-(3-(dimetilamino)propil)-3-etilurea
Cabaser
Cabaseril
Dostinex
FCE 21336
FCE-21336
Galastop
difosfato de 1-etil-2-(3'-dimetilaminopropil)-3-(6'-alilergolin-8'-beta-carbonil)urea
difosfato de cabergolina
Scope note: Derivado de ergolina y agonista de los receptores D2 de la dopamina que inhibe la secreción de PROLACTINA. Se usa en el tratamiento de la HIPERPROLACTINEMIA y para suprimir la lactación después del parto por razones médicas. La cabergolina se usa también en el tratamiento de la ENFERMEDAD DE PARKINSON.
Descriptor Portuguese: Cabergolina
Descriptor French: Cabergoline
Entry term(s): 1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea
1-Ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate
Cabaser
Cabaseril
Cabergoline Diphosphate
Dostinex
FCE 21336
FCE-21336
Galastop
Tree number(s): D03.132.327.287.131
D03.633.400.439.197
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000077465
Scope note: An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion. It is used in the management of HYPERPROLACTINEMIA, and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antiparkinson Agents
Dopamine Agonists
Registry Number: LL60K9J05T
CAS Type 1 Name: Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propen-1-yl)-, (8beta)-
Public MeSH Note: 2019; CABERGOLINE was indexed under ERGOLINES 1985-2018
History Note: 2019 (1985)
DeCS ID: 57653
Unique ID: D000077465
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/07/03
Cabergoline - Preferred
Concept UI M0136060
Scope note An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion. It is used in the management of HYPERPROLACTINEMIA, and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE.
Preferred term Cabergoline
Entry term(s) 1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea
FCE 21336 - Narrower
Concept UI M0136057
Preferred term FCE 21336
Entry term(s) FCE-21336
Cabaser - Narrower
Concept UI M0136055
Preferred term Cabaser
Cabaseril - Narrower
Concept UI M000640795
Preferred term Cabaseril
Dostinex - Narrower
Concept UI M000640796
Preferred term Dostinex
Galastop - Narrower
Concept UI M0136059
Preferred term Galastop
Cabergoline Diphosphate - Narrower
Concept UI M0322534
Preferred term Cabergoline Diphosphate
Entry term(s) 1-Ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey